Safety and Efficacy of Percutaneous Cryoablation for Thoracic Malignancies
Phase 2
- Conditions
- Primary lung cancer, metastatic lung cancer, mediastinal tumor, chest wall tumor
- Registration Number
- JPRN-UMIN000014996
- Lead Sponsor
- School of Medicine, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1)abnormal coagulability 2)active bleeding 3)active infection 4)untreatable brain tumor 5)general anesthesia 6)impossible to communicate 7)prognosis limiting lesion out of thorax 8)more than 10 tumors 9)judged as inadequate by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes are treatment-related mortality, morbidity, local control and overall survival.
- Secondary Outcome Measures
Name Time Method